Lacosamide Jubilant (Lacosamide)

Lacosamide is an antiepileptic drug indicated for the treatment of partial‑onset seizures in epilepsy.

• Partial‑onset seizures: reduces seizure frequency when used as add‑on therapy.
• Epilepsy (adjunctive): improves overall seizure control in patients already on other antiepileptic medications.
• Focal epilepsy: provides additional seizure protection alongside standard regimens.

• Lacosamide enhances the slow inactivation of voltage‑gated sodium channels, stabilizing neuronal membranes and reducing hyper‑excitability. It also binds to collapsin response mediator protein‑2 (CRMP‑2), modulating neuronal signaling pathways that contribute to seizure generation. These combined actions decrease the likelihood of abnormal neuronal firing that underlies epileptic seizures.

Lacosamide may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects

• Dizziness: sensation of light‑headedness or unsteadiness.
• Fatigue: feeling unusually tired or weak.
• Nausea: mild to moderate stomach upset.
• Headache: persistent or intermittent pain.
• Diplopia: double vision.
• Somnolence: increased sleepiness.

Serious or Rare Side Effects

• Suicidal ideation: thoughts of self‑harm requiring immediate evaluation.
• Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis.
• Cardiac arrhythmia: irregular heart rhythm, especially in patients with pre‑existing conditions.
• Hepatic injury: signs of liver dysfunction including jaundice.
• Blood dyscrasias: abnormal blood counts, such as neutropenia.
• Allergic reactions: anaphylaxis or severe hypersensitivity.

Before initiating therapy with Lacosamide, several safety considerations should be addressed.

• Renal impairment: assess kidney function and adjust dosing if necessary.
• Hepatic impairment: monitor liver enzymes regularly.
• Concomitant CNS depressants: observe for enhanced sedation or respiratory depression.
• Pregnancy: risk unknown; prescribe only when benefits outweigh potential risks.
• Driving and operating machinery: avoid until individual response is known.
• Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Lacosamide can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid)

• Carbamazepine: may significantly reduce lacosamide plasma levels.
• Phenytoin: can lower lacosamide concentrations, reducing therapeutic effect.
• Strong CYP3A4 inducers (e.g., rifampicin): may decrease lacosamide exposure.

Moderate Interactions (Monitor Closely)

• CNS depressants (benzodiazepines, opioids): increased risk of sedation and respiratory depression.
• Alcohol: may enhance dizziness and drowsiness.
• Anticoagulants (warfarin): monitor INR for potential alterations in anticoagulant effect.